Evaluation of serum14-3-3η protein and Sema3A levels in rheumatoid arthritis: diagnostic and prognostic value

• Main Authors: Nivine Fathi Darwish, Shymaa Ahmed Hablas, Nivin Naeem Baiomy, El Sayed Mohamed Hamid Rageh
• Format: Article
• Language: English
• Published: SpringerOpen 2020-12-01
• Series: Egyptian Rheumatology and Rehabilitation
• Subjects: Rheumatoid arthritis; Serum14-3-3η protein; Serum Sema3A; Proinflammatory mediators
• Online Access: https://doi.org/10.1186/s43166-020-00044-z

Abstract Background Serum14-3-3η protein plays an important role in the pathogenesis of rheumatoid arthritis (RA) as it is a joint-derived proinflammatory mediator. Semaphorin3A (Sema3A) plays an immune regulatory and bone remodeling role in many autoimmune diseases. Their role in rheumatoid arthritis needs to be evaluated for diagnostic and prognostic prospective values. Results The serum level of protein 14-3-3n was significantly higher in patients with RA than those in healthy controls. Serum 14-3-3η has a significant positive correlation with RF and ACPA, but not with either DAS28, ESR, or CRP. Serum 14-3-3η levels were significantly correlated with radiographically assessed joint damage. Serum Sema3A levels were decreased in rheumatoid arthritis patients compared to controls. There were also negative correlations with disease duration and activity score (DAS28), ESR, CRP, and RF. Conclusion The discriminative ability of 14-3-3η was comparable to RF and ACPA enhancing its diagnostic capacity. Sema 3A might serve as a predictive marker for radiographic severity and could have a potential therapeutic role in RA.